| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses
|
Napolitano, Valeria
|
|
|
29 |
5 |
p. 774-784.e8
|
artikel
|
| 2 |
An allosteric inhibitor of bacterial Hsp70 chaperone potentiates antibiotics and mitigates resistance
|
Hosfelt, Jordan
|
|
|
29 |
5 |
p. 854-869.e9
|
artikel
|
| 3 |
A non-reactive natural product precursor of the duocarmycin family has potent and selective antimalarial activity
|
Alder, Arne
|
|
|
29 |
5 |
p. 840-853.e6
|
artikel
|
| 4 |
Chemical strategies to understand and manipulate host-pathogen interactions
|
Wagner, Bridget K.
|
|
|
29 |
5 |
p. 711-712
|
artikel
|
| 5 |
Clionamines stimulate autophagy, inhibit Mycobacterium tuberculosis survival in macrophages, and target Pik1
|
Persaud, Rosanne
|
|
|
29 |
5 |
p. 870-882.e11
|
artikel
|
| 6 |
Control of host PTMs by intracellular bacteria: An opportunity toward novel anti-infective agents
|
Stévenin, Virginie
|
|
|
29 |
5 |
p. 741-756
|
artikel
|
| 7 |
FADS2-dependent fatty acid desaturation dictates cellular sensitivity to ferroptosis and permissiveness for hepatitis C virus replication
|
Yamane, Daisuke
|
|
|
29 |
5 |
p. 799-810.e4
|
artikel
|
| 8 |
Glycopeptidolipid glycosylation controls surface properties and pathogenicity in Mycobacterium abscessus
|
Daher, Wassim
|
|
|
29 |
5 |
p. 910-924.e7
|
artikel
|
| 9 |
Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profiling
|
Li, Michael
|
|
|
29 |
5 |
p. 883-896.e5
|
artikel
|
| 10 |
Identification of covalent inhibitors that disrupt M. tuberculosis growth by targeting multiple serine hydrolases involved in lipid metabolism
|
Babin, Brett M.
|
|
|
29 |
5 |
p. 897-909.e7
|
artikel
|
| 11 |
Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine
|
Hulce, Kaitlin R.
|
|
|
29 |
5 |
p. 785-798.e19
|
artikel
|
| 12 |
Integrated genomics and chemical biology herald an era of sophisticated antibacterial discovery, from defining essential genes to target elucidation
|
Warrier, Thulasi
|
|
|
29 |
5 |
p. 716-729
|
artikel
|
| 13 |
Integrating complex host-pathogen immune environments into S. aureus vaccine studies
|
Tsai, Chih-Ming
|
|
|
29 |
5 |
p. 730-740
|
artikel
|
| 14 |
Multi-protein complexes as drug targets
|
Gestwicki, Jason E.
|
|
|
29 |
5 |
p. 713-715
|
artikel
|
| 15 |
Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo
|
Georgiev, George I.
|
|
|
29 |
5 |
p. 811-823.e7
|
artikel
|
| 16 |
Small-molecule HIV-1 entry inhibitors targeting the epitopes of broadly neutralizing antibodies
|
Jiang, Shibo
|
|
|
29 |
5 |
p. 757-773
|
artikel
|
| 17 |
The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance
|
Murithi, James M.
|
|
|
29 |
5 |
p. 824-839.e6
|
artikel
|
Tijdschrift beschrijving